Zimmer Biomet reports third quarter 2026 results and updates full-year guidance
FROM THE WIRE · PRNEWSWIRE.COM
Third quarter net sales of $2.063 billion increased 3.1% on a reported basis and 3.7% on a constant currency1 basis Third quarter diluted earnings per share were $1.00, a decrease of 13.8%; adjusted1 diluted earnings per share were $1.90, consistent with the prior year period…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralFull-year guidance update from a large medtech company, relevant for the sector.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Third-quarter net sales were $2.063 billion, up 3.1% on a reported basis.
- 02Diluted EPS was $1.00, down 13.8%.
- 03Adjusted diluted EPS was $1.90, consistent with the prior-year period.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets